Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$46.5 - $79.14 $943,578 - $1.61 Million
-20,292 Reduced 65.46%
10,708 $505,000
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $1.67 Million - $2.25 Million
26,500 Added 588.89%
31,000 $2.22 Million
Q1 2022

May 16, 2022

BUY
$74.15 - $99.36 $333,675 - $447,120
4,500 New
4,500 $364,000
Q4 2021

Feb 14, 2022

SELL
$86.01 - $102.89 $611,015 - $730,930
-7,104 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $601,708 - $684,186
7,104 New
7,104 $621,000
Q2 2020

Aug 14, 2020

SELL
$34.32 - $62.43 $319,176 - $580,599
-9,300 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$32.64 - $73.63 $303,552 - $684,759
9,300 New
9,300 $367,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.